ePharmacy market seen reaching $566.28B by 2035

The global ePharmacy market is projected to grow from $99.49 billion in 2025 to $566.28 billion by 2035, according to Market Research Future. The report points to e-prescription mandates, pharmacy closures and super-app distribution as the main forces reshaping how patients fill prescriptions and buy over-the-counter products.

Why it matters: - The ePharmacy market is moving from a convenience channel to a core part of medication access and chronic-care delivery. - The shift could redirect prescription volume away from physical counters and toward mail-order, app-based and same-day delivery models. - Growth is likely to matter most in markets with digital prescribing mandates, pharmacy deserts and strong mobile commerce adoption.

What happened: - Market Research Future projects the global ePharmacy market will rise from $99.49 billion in 2025 to $566.28 billion by 2035. - The forecast implies an 18.9% compound annual growth rate from 2026 to 2035. - The market was valued at $119.24 billion in 2026, the first forecast year in the report. - Germany’s legislative e-prescription requirement took effect for all public insurance on Jan. 1, 2024. - That mandate moved about 500 million annual prescriptions onto a digital system. - Almost 2,100 chain pharmacies are expected to close through 2026, mostly in low-density and low-margin areas. - Amazon Pharmacy said in June 2025 it would expand same-day delivery to about 4,500 U.S. cities and towns in 2026.

The details: - Prescription drugs held the largest drug-type share in 2025 at 66.8% of revenue. - Over-the-counter drugs were the fastest-growing drug-type segment, with a 20.1% CAGR for 2026 to 2035. - Cold and flu remedies were the largest product category in 2025 at 23.4% share. - Vitamins and dietary supplements were the fastest-growing product type, with a 21.0% CAGR. - Skin care reached $16.71 billion in 2025. - Weight loss products are forecast to grow at a 19.8% CAGR. - Diabetes was the largest therapeutic area in 2025 at $29.65 billion. - Cardiovascular therapies held an 18.6% share in 2025. - Gastrointestinal disorders are the fastest-growing therapeutic area, with a 21.3% CAGR. - Respiratory products reached $13.13 billion in 2025. - Desktop users held the largest platform share in 2025 at 44.9%. - Mobile users represented 55.1% of 2025 revenue and are forecast to grow at a 21.4% CAGR. - North America accounted for 40.1% of 2025 revenue. - Europe ranked second with 24.6% of the market in 2025. - Asia-Pacific is the fastest-growing region, with a 19.3% CAGR. - China held 44.6% of Asia-Pacific revenue. - India is the fastest-growing Asia-Pacific market, with a 22.13% CAGR. - South America generated $4.88 billion in 2025. - The Middle East and Africa held 3.6% of global revenue in 2025. - The top five participants held roughly 30% to 34% of global revenue. - Market Research Future named Amazon Pharmacy, CVS Health, Cigna’s Express Scripts, JD Health, Alibaba Health, Redcare Pharmacy and DocMorris among the key players.

Between the lines: - Germany’s e-prescription mandate and similar digital-script systems in Europe show how regulation can force adoption faster than consumer marketing alone. - Pharmacy closures create a structural opening for delivery and mail-order providers, especially where patients face long drives to the nearest dispensing location. - Super-app storefronts in China and India lower customer acquisition costs by embedding pharmacy access inside existing payment and delivery ecosystems. - Cold-chain logistics expand the number of high-value therapies that can be sold remotely, improving revenue per order. - The report suggests the market is becoming less about single transactions and more about recurring medication management.

What's next: - Amazon Pharmacy’s 2026 delivery expansion will test how much volume national logistics can pull from legacy chains. - Continued store closures among large pharmacy chains are likely to accelerate migration to digital refill channels. - European and Asia-Pacific operators are expected to keep investing in automation, logistics and app-based prescribing flows. - The report sees growth opportunities in chronic-care subscriptions, emerging markets, manufacturer direct channels and data-driven adherence tools.

The bottom line: - ePharmacy is shifting from a niche convenience model to a large-scale distribution layer for prescriptions and recurring care.